Weight Management
Fragment 176-191
A C-terminal HGH fragment associated with lipolysis.
Released with a certificate of analysis. Prescription required.
About Fragment 176-191
A C-terminal HGH fragment associated with lipolysis. InterX Pharmacy compounds Fragment 176-191in a licensed 503A facility under USP <797> and <800> standards, and releases every batch with its own certificate of analysis.
Available to licensed providers for patient-specific prescriptions and office-use orders. Dosing and protocols are determined by the prescriber. This page is informational and not medical advice.
Specifications
- Strength
- 5 mg/vial
- Form
- Lyophilized powder
- Presentation
- Single-dose sterile vial
- Purity
- ≥ 98% by HPLC
- Testing
- Identity, potency, sterility
- Storage
- Refrigerate, protect from light
- Release
- Certificate of analysis per lot
Prescribing information
How Fragment 176-191 is supplied.
How supplied
Injectable, 5 mg/vial. Lyophilized for reconstitution.
Storage
Refrigerate and protect from light. Use within the assigned beyond-use date.
Handling
Prepared under aseptic technique. Prescription required for dispensing.
Documentation
Each lot ships with its certificate of analysis and lot record.
Full prescribing details are provided to licensed providers. Dosing and indications are determined by the prescriber. This page is informational and not medical advice.
More in Weight Management
Order Fragment 176-191 with proof.
Open a provider account or talk to our pharmacy team about this formulation.